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Objectives. This study was performed to investigate the long-
term outcome of patients with unstable angina within subgroups
of the Braunwald classification.
Background. Long-term follow-up studies of patients with
unstable angina are rare and date from more than two decades
ago. This study was performed to establish the prognosis of
different subgroups of patients with unstable angina (Braunwald
criteria) during a 7-year follow-up period.
Methods. We registered a well defined group of 417 consecutive
patients, admitted to the hospital for suspected unstable angina.
The definite diagnosis was unstable angina in 282 patients (68%)
and evolving myocardial infarction in 26; in 109 patients (26%),
the symptoms were attributed to other or nonspecific causes.
Patients with definite unstable angina were subclassified accord-
ing to the Braunwald classification. Survival, survival without
infarction and survival without infarction or intervention were
determined for each class.
Results. After a median follow-up period of 94 months, the
mortality rate in the first year was 6% and 2% to 3% in the
following years. The frequency of revascularization was 47% in the
first year, and that for myocardial infarction was 11% in the first
year and 1% to 3% thereafter. The Braunwald classification
appeared to be appropriate for risk stratification in the first year.
However, at 7 years the event rates in all classes were similar. In
particular, the Braunwald classification had no long-term impact
on mortality or infarction rates. However, patients with acute
angina at rest or postinfarction angina and patients with extensive
anginal treatment had high intervention rates.
Conclusions. To our knowledge, this study is the first to
demonstrate that despite a complicated course during the first
year, current management results in good long-term outcome in
patients with unstable angina.
(J Am Coll Cardiol 1998;31:1534–9)
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The onset of unstable angina portends a significant risk for the
occurrence of major cardiac events, including death and myo-
cardial infarction. In previous studies (1–3), 1-year mortality
rates varied from 2% to 18% and 1-year myocardial infarction
rates from 7% to 21%. Long-term follow-up reports of patients
with unstable angina are rare (4). We report the 7-year
follow-up results of 282 consecutive patients who were admit-
ted with unstable angina, to establish the incidence and
prognosis of the various subgroups of unstable angina. The
Braunwald classification (5) appeared to be an appropriate
instrument for identifying groups of patients with different
levels of risk at 6 months (6). The validity of this classification
for longer term follow-up was assessed.
Methods
Classification of patient groups. During a 7-month period
in 1988 and 1989, a prospective registry was maintained in two
hospitals in Rotterdam. Four hundred seventeen consecutive
patients with suspected unstable angina, according to the
attending physician, were included in the study. The admission
diagnosis, suspected unstable angina, was based on a history of
chest pain at rest or at minimal exertion, probably of ischemic
origin, without signs of acute infarction or other causes of chest
pain. Electrocardiographic (ECG) changes were not required
for inclusion. Secondary referrals from other hospitals for
treatment were excluded. The final diagnosis as registered 24
to 48 hours after admission was based on evolution of symp-
toms and documentation of objective ECG criteria during
observation or elevated enzyme levels. Three final diagnoses
were determined: acute myocardial infarction, definite unsta-
ble angina and atypical chest pain or other disease (7). A final
diagnosis of myocardial infarction was defined as the occur-
rence of serum creatine kinase levels above twice the local
upper limit of normal. Definite unstable angina was based on
the assessment of symptoms and on documentation of ECG
changes (see Data collection). Patients with an initial infarc-
tion who had recurrent anginal pain after 24 h were classified
as having postinfarction unstable angina. For patients with
definite unstable angina, the final classification was made after
24 to 48 h of observation according to the Braunwald classifi-
cation of unstable angina (5): Severity 5 new onset of severe or
accelerated angina without pain at rest (class I 5 no rest pain);
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angina at rest within the past month but not within the
preceding 48 h (class II 5 subacute angina at rest); or angina
at rest within 48 h (class III 5 acute angina at rest). Clinical
circumstances 5 unstable angina in the absence of an extracar-
diac condition (class B 5 primary unstable angina) or that
developed within 2 weeks after acute myocardial infarction
(class C 5 postinfarction unstable angina). Patients with
secondary angina, related to noncardiac conditions (class A),
were excluded from the analysis. ECG changes 5 present or
absent. Intensity of treatment 5 none or one of the major
antianginal drugs, beta-adrenergic blocking agents, long-acting
nitrates and calcium antagonists (minimal therapy); more than
one of these drugs (extensive oral therapy) or extensive use of
antianginal therapy, including intravenous nitrates (maximal
therapy).
Data collection. The data were prospectively collected and
focused on the various decision moments during the hospital
stay. Demographic data, history and characteristics of presen-
tation were recorded at admission. During the hospital period,
a log was kept of new pain episodes, new infarction or death
and diagnostic and therapeutic measurements, such as ECG
findings, exercise tests results, medication and intervention.
ECGs were coded with respect to presence or absence of Q
waves, signs of left ventricular hypertrophy or intraventricular
conduction disturbances and ST segment elevation or depres-
sion $0.1 mV or T wave inversion, or both. ECG changes were
defined as additional ST segment elevation or depression $0.1
mV or T wave deviation $0.1 mV versus that on the baseline
ECG in the absence of pain.
Follow-up. Postdischarge data were obtained from munic-
ipal registries, clinical records, general practitioners and pa-
tients. Patients were followed up for a median of 94 months
(range 85 to 100) for the occurrence of death, infarction,
revascularization (coronary bypass or angioplasty) and hospital
admission. Medication at 1, 3, 5 and 7 years was recorded.
Statistical analysis. Patient groups were compared with a
Student t test for continuous variables and a chi-square test for
categoric data. End points are presented in terms of “survival,”
“survival without myocardial infarction” and “infarction-free
survival without revascularization.” The probability of these
end points is presented as Kaplan-Meier curves (8). Differ-
ences between curves were analyzed with log-rank tests (9). A
stepwise Cox proportional hazards model was used to select
predictors of (event-free) survival, specifically to relate the
various Braunwald classes to prognosis. The following vari-
ables were considered: age; gender; history of myocardial
infarction; hypertension; Braunwald classes I to III (severity),
B and C (clinical circumstances); ECG changes; and intensity
of medical treatment during the hospital period. All analyses
were performed for the 282 patients with definite unstable
angina.
Results
Patients. A total of 417 patients were enrolled in an
observational study of suspected unstable angina, of whom 6
died in the hospital (6). The definite (final) diagnosis was
unstable angina in 282 patients (68%) and acute myocardial
infarction in 26; 109 patients (26%), the symptoms were
attributed to other or nonspecific causes. The median age of
patients with unstable angina was 63 years (range 31 to 89),
64% were men, 46% had a previous infarction, 23% had a
history of unstable angina, and 27% had undergone previous
revascularization (coronary artery bypass graft surgery
[CABG] in 15%, percutaneous transluminal coronary angio-
plasty [PTCA] in 12%). Of the 282 patients with a final
diagnosis of unstable angina, 20% were assigned to Braunwald
class I, 35% to class II and 45% to class III. A total of 16%
were classified as having postinfarction angina (class C), and
63% had ECG changes. Complete 7-year follow-up informa-
tion could be obtained for 278 patients (99%) with unstable
angina. The median follow-up period was 94 months (range 6
to 100).
Medical therapy. Antianginal treatment (beta-blockers, ni-
trates or calcium channel blockers, alone or in combination)
was prescribed for 87% of patients at hospital discharge and
65% at the end of the first year and decreased to 51% at 7
years. Extensive treatment (more than one antianginal drug)
decreased from 35% at the end of the first year to 26% at 7
years. Aspirin was routinely prescribed in two-third of patients
and did not change during follow-up. Long-term oral antico-
agulant treatment during follow-up was frequent (13% to
19%). The use of cholesterol-lowering therapy increased from
2% at discharge to 29% at 7 years. After 7 years, 46% of
patients were in Canadian Cardiovascular Society angina class
I, 23% were in class II, 20% were in class III, and 11% were in
class IV.
Postdischarge course. The initial course of the 282 patients
after hospital discharge was complicated (Fig. 1). Myocardial
infarction in the first year was observed in 31 patients (11%);
the subsequent yearly infarction rate was low, ;1.9%. Revas-
cularization procedures were performed predominantly during
the first year. PTCA or CABG or both, was performed in 141
patients (50%) at 7 years. Survival rates at 1, 3, 5 and 7 years
were, respectively, 94%, 88%, 81% and 76%. The mortality
between the first and seventh year averaged 3.4%/year, 1.2%
higher than the standardized mortality rate for the general
population of the same age. Survival without infarction and
infarct-free survival without intervention are shown as Kaplan-
Meier curves for the different subgroups (Fig. 2). Long-term
and infarct-free survival were similar with respect to severity
(Braunwald classes I to III). Early urgent intervention (,1
month), especially angioplasty, was particularly frequent in
class III patients, whereas interventions for class I patients
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
ECG 5 electrocardiogram, electrocardiographic
PTCA 5 percutanous transluminal coronary angioplasty
1535JACC Vol. 31, No. 7 VAN DOMBURG ET AL.
June 1998:1534–9 LONG-TERM OUTCOME OF UNSTABLE ANGINA
were spread throughout the first year. After 1-year follow-up,
infarct-free survival without intervention was similar in classes
I and III. Class II patients (no angina at rest within 48 h) had
fewer interventions in the first year after hospital discharge.
However, in contrast to classes I and III, interventions were
performed with a constant rate during the total follow-up
period. Thus, after 7 years, the rates were similar in all severity
classes. Survival without infarction or CABG and without
PTCA was significantly higher (p , 0.05) in patients with
primary unstable angina (class B) than in postinfarction pa-
tients (Fig. 3). No significant differences were observed in
event-free survival when the patient group was classified with
respect to the presence or absence of ECG changes during the
hospital period (Fig. 4).
Predictors of 7-year outcome. The only predictors of 7-year
mortality by univariable analysis were age ($70 years) and
diabetes (Table 1). For all three outcomes (death; death or
infarction; death or infarction or intervention), the adjusted
risk ratios were estimated using the Cox proportional hazards
model. Advanced age ($70 years) and diabetes remained
independent predictors of mortality (Table 1). Survival without
infarction was related to age, diabetes and male gender.
Angina at rest within 48 h (class III) and postinfarction angina
(class C) were independent risk factors for the combined end
point of survival, infarction or intervention, as were the use of
two or more antianginal drugs during the hospital period and
male gender.
Discussion
Long-term follow-up studies of patients with unstable an-
gina are rare and date from more than two decades ago (1,10).
Since then, the practice of cardiology and the definition of
unstable angina have changed. We registered a well defined
group of 282 consecutive patients with unstable angina from
among 417 patients admitted to the hospital for chest pain.
The selection of patients immediately after admission ensured
that the whole spectrum of unstable angina was included in this
registry. This inclusion is in contrast to most other studies of
unstable angina that included only selected patients, restricted
by age (11,12), absence of recent myocardial infarction or
CABG, duration of pain episodes (13–15) or the presence of
ischemic signs on the ECG (15–17). In most studies, patients
were selected 24 to 48 h after admission, when myocardial
infarction had been ruled out by serial enzyme analysis. In
contrast, the only exclusion criteria in the present study were
evidence of other disease assumed to be the cause of the chest
pain and referral from other hospitals for further treatment of
patients for whom a complete diagnosis already had been
established.
Long-term outcome. To our knowledge the present data
are the first to demonstrate that after a complicated first-year
course, the long-term outcome of patients with unstable angina
is good, with low subsequent rates of infarction and interven-
tion. The mortality rate in the first year was 6% and 2% to 3%
in the following years. Hospital admission because of chest
pain at 1, 3, 5 and 7 years was, respectively, 5%, 4%, 3% and
2%. This good prognosis is comparable with that of other
reports (2,12,15,18,19), although those studies were limited to
2 years of follow-up, and may be related to the high early
Figure 1. Proportion of events in 282 patients with unstable angina.
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intervention rate and improved medical therapy for this con-
dition. Revascularization was particularly frequent during the
hospital period and the subsequent first year, when 47% of
patients underwent CABG or PTCA. The significant decrease
in subsequent years is remarkable and reflects the “durability”
of current revascularization techniques and effective antiangi-
nal therapy.
Medication and revascularization. Antianginal treatment
remained frequent, with a constant group of 25% of patients
taking two or more antianginal drugs (beta-blockers, calcium
antagonists or nitrates). Most patients were taking aspirin
(67%) or oral anticoagulant agents (17%). Most bypass pro-
cedures were performed in patients with accelerated angina
without pain at rest (class I), whereas most coronary angio-
plasty procedures were performed in patients with angina at
rest within 48 h (class III). Patients with angina at rest without
pain within 48 h (class II) had a lower initial intervention rate
than the other subgroups.
Braunwald classification. The Braunwald classification of
unstable angina has been validated previously for short-term
outcome (20–23) and appears to be appropriate for risk
stratification in the first year when most events occur. How-
ever, at 7 years the event rates in all Braunwald classes were
similar. In particular, the Braunwald classification had no
long-term impact on mortality or infarction rates. However,
patients with acute angina at rest (pain within 48 h [class III])
or postinfarction angina (class C) and patients with extensive
antianginal treatment had high intervention rates, as might be
expected. Quality of life might improve were revascularization
performed earlier in patients with angina at rest without pain
within 48 h (class II), although 30% of all patients survived for
7 years without intervention or infarction.
Conclusions. The Braunwald definitions appear to be ap-
propriate for risk stratification, especially in the first year when
most events occur. However, at 7 years the event rates were
similar in all classes of unstable angina. The present study
demonstrates that despite a complicated course during the first
year, the long-term outcome is good in patients with unstable
angina, with a high early intervention rate and low rates of
infarction and intervention thereafter.
Figure 2. Rates of survival (top); survival without infarction (middle);
and survival without infarction, CABG or PTCA (bottom) by class of
severity in 282 patients with unstable angina. Figure 3. Rates of survival (top); survival without infarction (middle);
and survival without infarction, CABG or PTCA (bottom) by clinical
diagnosis in 282 patients with unstable angina.
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*More than one antianginal drug (see Methods). CI 5 confidence interval;
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acute angina at rest; ECG 5 electrocardiographic; RR 5 relative risk.
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